Sections
Shows
Events
SEC to take decision on antiviral COVID-19 pill today, say sources
SEC recommends DCGI to approve Bharat Biotech's Covaxin for children between 2-18 years of age
COVID-19 expert panel recommends Bharat Biotech jab COVAXIN for emergency use authorisation
